Search Results
Results found for "Zhou Y"
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
During years, several studies have depicted the pivotal role of the cytoskeleton and lipid microdomains
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
G-protein-coupled receptors (GPCRs) are involved in a wide array of physiological and disease functions, yet
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
It is as yet unknown whether these CB1 receptors contribute to pathways underlying skeletal muscle biological
- Dr. GPCR Summit 2022 is coming!
presenting a trainee talk, a poster, or a pre-recorded talk Become a site member for FREE and submit your
- Join Us Today!
GPCR Ecosystem is under construction and dozens of your colleagues are enjoying its benefits!
- Join Us Now!
Do you want to be part of it?
- Addex Raises $10 Million In Equity Financing
$6.50 per ADS, will become exercisable in 60 days after their date of issuance and will expire six years
- Learn about Dr. GPCR Ecosystem!
💻Did you know that Dr. GPCR is much more than a podcast? Come check out the brand new Dr.
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
This is a highly prestigious international award – exemplified by the fact that other winners this year
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
US$100 million, with the amount to be recognized as revenue in the fourth quarter of the financial year
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers
- Novo Nordisk moves to strengthen obesity efforts
January 2022 "After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position Although specific details of the collaboration are yet to be released, EraCal has confirmed that the
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
the fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience
- Dr. GPCR Summit is FREE for Ecosystem site members!
📢 Did you know that this 3rd Edition of the Dr.
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
cell and the astonishing diversity of diseases are just two reasons why researchers typically require years
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
dedicated to funding lifesaving oncology research, spent £388 million on cancer research last fiscal year
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Ligand-based pharmacophore modeling was performed since no 3D structure of human β3 -AR is yet available
- 2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany
August 2022 "We are happy to announce you our 2nd IRN i-GPCRnet meeting that will be held at the University
- Addex raises $4.2 million in equity financing
$1.90 per ADS, will become exercisable in 60 days after their date of issuance and will expire five years
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
with Classic CAH - Two Phase 3 Global Registrational Studies Currently Underway in Pediatric (2–17 years of age) and Adult (18 years of age and older) Patients with Classic CAH SAN DIEGO, June 13, 2022 -
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
and advance the development of new gastrointestinal therapeutics Tokyo, Japan, Cambridge, UK and New York USA – May 17, 2022 – Sosei Group Corporation, the international biopharmaceutical company, and New York
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences successful IPO on Nasdaq in February 2021, and successfully raised follow-on capital later that same year
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
Topline results from 40 subjects are expected in the second half of the calendar year."
- Illuminating the draggable GPCR-ome
Are you ready? Tomorrow is the day for another Dr. GPCR Virtual Cafe. Get yours now! https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe
- Dr. Juan José Fung - Dr. GPCR Podcast
Mark your calendars! The Dr. GPCR Podcast is back this week with a brand new episode.
- Dr. Marta Filizola - Dr. GPCR Podcast
You can also leave us a review on Apple Podcast!
- Unconventional GPCR-PKA Communication in the Hedgehog Pathway
Mark your calendars and get your ticket today! The Dr. GPCR Virtual Cafe is back!
- AELIS PHARMA launches their IPO for €25 million
Thank you to our shareholders, both historical and new, for their trust.
- Mark Schmeizl - Dr. GPCR Podcast
Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast










